Box3.4, Recommended options for inital controuertrsatment in sdutts and sdoissesnts resenting sympiome ratarro ntl contro ‘Falla eyrpions reed oc SABA les an face amoosin0 | Noconllr (Evidence woking de b asthma in ast meni anna isk fcr for exaowtatons (Bot 225, p17} inducing no exacaaons ine at er irfeqperdasthna eyrplare bil the palerthas one ormore cok Lowdose OS™ (Evtenae OF ‘ators for excerblions (Box2-28)- 29 low ng uncon. ot exooetbaton reqling OCS he as year or has everbeenh Intense cave fo astra ‘athe oproms or needior SABA beineeniatce armen ard | Low dose IGS™ (Esdence 8) taice a WEEK, orn ates cue asina once or more amonth ‘Aathms eyrptoms or need or SABA move fan tale a week Low dose SS" (Evcence AD Other est eteatve clionsae LTRA pesptire Tioublasome aera syrploms mod days oc waking dele athrna | Wgitumigh cose ICS! (Evidence Al. or roe. week ormere, especialy any tk farses ax 2-28) —_|\ lw dose ISSLABA? (idence A) Tra asivra preseriaon is wi severey uncorawes alta (| Shorlcourse of oral corboosics AND wean acute exacerbation ‘Sar rear conor eaiment cps 2 Batore starting intial controuer treatment “+ Record evence for ine dagnoss of sstima:#eGoesine (+) Recon ne patents leve! of eymptom erat ard rik facts, ung ung tuneson (Box 2-2, p17) ‘+ Consiger factors intuensng onolce of yestnent (20x 23, B27) (© Ensure hat ne palert can use Me lmnaer comecty ‘+ Senenue an appainimentfor a folds wit After starting Intlal controller treatment ‘Review parts resporee (Sox 2-2) alr Simona, creates depending on Ghia geno, {+ Seer 36 tor eeanmendstons tor ongang testment and oer Rey Management ees {Step down renent ance good cant has been ransinedfor3 mort (ox 37, 50), 12 wed cana LAK ngage TRA ana ip wget OC we cra BA Cg eraaeat “Tai anaen witanc hom daa stan inna, anger oct Tine tratiraranin ed nara a sete ty Vara mea arora eeraweatese't x weal lew fears eae mete cece os nectar eee ge aber mang ie ee Co oe te ‘SteAatoe a econaters tema popes ‘oatascona teaumtg alae 2 nba 2 * Conmaona ering Sap Sin Be 3